One approach to avoiding infection of CAR-T cells is by knocking out the CCR5 gene via ex vivo genetic editing using zinc-finger nucleases (ZFNs), transcription activator-like nucleases (TALENs) or CRISPR-Cas9 technology [34,51]. This evidence concerns the gene CCR5 and infection.